학술논문
Blood first line ready screening trial ( B-F1RST) and blood first assay screening trial (BFAST) enable clinical development of novel blood-based biomarker assays for tumor mutational burden (TMB) and somatic mutations in 1L advanced or metastatic
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
15698041